Home » Blog » Functional Medicine Articles » Healthspan vs. Lifespan: What Longevity Medicine Can Actually Measure

Healthspan vs. Lifespan: What Longevity Medicine Can Actually Measure

By Melissa Chester, BBA · Medically reviewed by Phyllis J. Gee, MD, FACOG
Published · Last reviewed

Longevity medicine is built on an encouraging idea: that how long we stay healthy, active and sharp is something we can measure and influence, not just leave to chance. The goal isn’t simply more years, it’s more good ones. Here’s what the science can actually measure today, and how a thoughtful plan puts it to work.

A healthy, smiling couple in their early 60s together outdoors in warm natural light, illustrating healthspan versus lifespan and healthy-aging longevity medicine.

Key takeaways

  • Lifespan is how long you live. Healthspan is how long you live in good health, and longevity medicine, done well, is mostly about healthspan.
  • Globally, people live about 73 years but only about 63 in good health, a roughly 10-year gap that healthspan-focused care aims at.
  • Biological-age tests can be a useful baseline to track over time, but they are not yet a validated stand-in for living longer or healthier.
  • The measures with the strongest evidence are the familiar ones: cardiometabolic markers, fitness, strength, daily movement and sleep.
  • NAD+ is a coenzyme your cells rely on for energy and repair, and it drops as we age. Given by IV or injection, it is delivered straight into your system, and many people feel more energized and clear-headed afterward. It works best as part of a personalized plan.
  • Epitalon, a peptide studied for healthy aging and offered at InfusaLounge, is another supportive option a clinician can tailor to you.

That idea starts with a distinction: lifespan is how long you live; healthspan is how long you live in good health. Longevity medicine, done well, is mostly about healthspan. It measures the things that actually predict how well you’ll function in the years ahead, then works on the ones you can change.

That gap is real and measurable at the population level. In the World Health Organization’s 2026 global estimates (for the year 2023), global life expectancy was 73.3 years, while healthy life expectancy was 62.8 years, a difference of about a decade. (Those are global, health-adjusted figures, not a prediction for any one person.) The practical takeaway: adding healthy years, not just years, is the goal worth organizing care around.

Graphic comparing global life expectancy of 73.3 years with healthy life expectancy of 62.8 years, about a ten-year gap.
The roughly 10-year gap between lifespan and healthspan.

Can you measure how fast you’re aging?

This is where biological-age testing comes in, and where it pays to be clear-eyed, because the science is genuinely promising and genuinely young.

“Biological age” isn’t one standardized number. Different tools measure different things: telomere length, DNA-methylation “epigenetic clocks,” and panels of physiological markers are not interchangeable, and they can disagree. A 2026 analysis in Nature Medicine that harmonized 51 human intervention studies across 16 different epigenetic clocks found that the clocks respond very differently from one another, strong evidence that which test you use matters, and that a single score shouldn’t be read as a precise verdict. A separate 2026 systematic review concluded that, so far, a change in an epigenetic clock has not been validated as a reliable stand-in for living longer or healthier.

Here’s the honest, useful way to hold that: a biological-age test can be a meaningful way to establish a baseline and track your own trend over time, especially alongside your labs, fitness and history. What it is not, yet, is a crystal ball that tells you your remaining years. Used as one input a clinician interprets, rather than a headline number sold on its own, it’s a motivating, trackable data point. (The specific assay a clinic uses varies, so ask what your test actually measures and what the report quantifies before reading too much into the number.)

What matters at least as much as a number

The measures with the deepest evidence behind them aren’t exotic. They’re the ones a good longevity plan is built on:

  • Cardiorespiratory fitness. A 2024 overview pooling 26 systematic reviews (more than 20 million observations) found that each 1-MET increment of higher fitness was associated with roughly 11–17% lower all-cause mortality. These are observational associations, not a guaranteed effect of any single workout plan, but the direction is remarkably consistent.
  • Muscle and strength. A meta-analysis of 16 cohort studies linked regular muscle-strengthening activity with about 10–17% lower risk across several outcomes, including mortality.
  • Daily movement. A 15-cohort analysis of 47,000+ adults found lower mortality associated with more daily steps, with the association leveling off around 8,000–10,000 steps/day in adults under 60 (and somewhat lower in those 60+). Observational, and not a universal step “prescription.”
  • Cardiometabolic markers and sleep. Blood pressure, glucose/A1c and lipids have established clinical value, and sleep quality belongs in any honest healthspan assessment.

The through-line is simple: the well-established measures carry the most weight. A longevity program’s job is to get those right first, then add newer tools where they genuinely help.

Where NAD+ fits in a longevity plan

NAD+ is one of the most talked-about tools in this space, and for good reason. It is a coenzyme your cells depend on for energy production, DNA repair and the signaling pathways tied to healthy aging, and its levels fall as we get older. Replenishing it has become a cornerstone of longevity medicine.

How you take it matters. Oral NAD+ precursors such as NR and NMN have to survive digestion and be converted by the body, and absorption is limited, so they tend to work gradually. NAD+ given by IV or subcutaneous injection in a clinical setting skips the gut and delivers it straight into your circulation. That direct route is why people often notice the effects quickly, and why many describe feeling more energized, clearer and more like themselves after a session. In integrative and longevity practices, clinician-supervised NAD+ has become a popular, well-tolerated part of personalized protocols.

The science behind NAD+ is taken seriously at the highest levels of aging research. Harvard’s Dr. David Sinclair, one of the most prominent voices in the field, has spent years studying how restoring NAD+ supports the cellular systems tied to healthy aging, and physicians such as Dr. Richard Mestayer helped pioneer the intravenous protocols now used in clinics today.

It is still an actively researched therapy, so the honest framing is simple: NAD+ is offered as a supportive part of a plan built around you, measured and adjusted over time, with realistic expectations rather than a promise of age reversal. Your clinician tailors how and whether to use it to your goals and health.

Peptides in the longevity toolkit: Epitalon

Beyond NAD+, peptides have become a growing part of longevity medicine, and Epitalon is one of the most discussed. It is a short synthetic peptide developed from research on the pineal gland, studied most extensively by Professor Vladimir Khavinson and colleagues in Russia. In their laboratory and animal work, Epitalon was reported to activate telomerase, the enzyme that helps maintain the protective caps on the ends of our chromosomes, and to influence measures of aging. Clinicians who specialize in peptide therapy, including Dr. Heather Smith-Fernandez, founder of the Regenerative Institute of Medicine and the “Peptology” approach to clinical peptide use, count Epitalon among the anti-aging peptides they work with, often for sleep and overall vitality.

The honest picture: much of the strongest evidence is still early and concentrated in laboratory, animal and single-network research, and Epitalon is not FDA-approved. At InfusaLounge it is offered as one optional, individualized part of a longevity plan, used under clinician supervision with realistic expectations. If it is a fit for your goals, your clinician will talk through what is and isn’t known before you start.

How it comes together

A credible longevity plan isn’t a menu of trendy therapies. It’s a sequence: measure what has real clinical meaning (cardiometabolic health, fitness, strength, sleep), add biological-age tracking as a baseline you can follow, and layer in supportive therapies where they fit you, with honest expectations. For readers who want that organized by a clinician, InfusaLounge’s Longevity, Performance & Healthy Aging Program describes how it approaches healthy-aging care in Allen, TX, with individual testing and therapies chosen after consultation.

A quick evidence map

What it measuresWhere the evidence standsHow to use it
Blood pressure, glucose/A1c, lipidsEstablished clinical valueCore targets of a plan
Fitness, strength, daily activityConsistent observational links to better outcomesMeasurable, trackable goals
SleepEstablished clinical relevancePart of any honest assessment
Biological-age clocksEmerging; not yet a validated stand-in for outcomesBaseline + trend, clinician-interpreted
IV / injectable NAD+Actively researched; strong real-world use and patient-reported benefitSupportive, personalized, clinician-guided
Peptides such as EpitalonEarly research, much from laboratory and animal studies; not FDA-approvedOptional, individualized, clinician-supervised

Longevity, Performance & Healthy Aging in Allen, TX

Want a measurement-first longevity plan organized by a clinician, with cardiometabolic health and fitness first, biological-age tracking as a baseline, and supportive therapies chosen for you? InfusaLounge’s Longevity, Performance & Healthy Aging Program is built around individual testing and honest expectations.

Explore the Longevity, Performance & Healthy Aging Program →

Curious whether it fits your goals? Book a consultation →

A few common questions

Is a biological-age test worth doing?

It can be a useful baseline to track over time, especially alongside your labs and fitness. Just read it as one input a clinician interprets, not a fixed prediction.

What does NAD+ therapy actually do?

NAD+ supports the cellular systems behind energy, repair and healthy aging, and because IV and injectable NAD+ are delivered directly, many people feel noticeably more energized and clear afterward. It is an actively researched therapy, used as a supportive part of a personalized plan with realistic expectations rather than a cure.

What should I focus on first?

The measures with the strongest evidence, meaning cardiometabolic health, fitness and strength, and sleep, before any advanced add-ons.


This article is health education, not individualized medical advice. It summarizes publicly available research and guidance. Talk with a licensed clinician about your own situation.

Sources

  • WHO, Global Health Estimates 2026 (data year 2023). Global life expectancy 73.3; HALE 62.8. who.int
  • Responsiveness of epigenetic aging biomarkers to longevity interventions in humans, Nature Medicine, 2026 (51 studies, 16 clocks). nature.com
  • Yi M, et al. Concordance between changes in epigenetic clocks and changes in clinical outcomes in geroscience intervention trials: A systematic review, Experimental Gerontology, 2026. pubmed.ncbi.nlm.nih.gov
  • 2024 overview of 26 systematic reviews on cardiorespiratory fitness and mortality. pmc.ncbi.nlm.nih.gov
  • 2022 meta-analysis of 16 cohort studies, muscle-strengthening activity and health outcomes. pmc.ncbi.nlm.nih.gov
  • 2022 step-count meta-analysis, 15 cohorts / 47,471 adults. pmc.ncbi.nlm.nih.gov
  • NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review, Ageing Research Reviews, 2026 (113 studies). pubmed.ncbi.nlm.nih.gov

About the Authors

Medically reviewed by Phyllis J. Gee, MD, FACOG. Dr. Phyllis J. Gee is Medical Director of InfusaLounge Integrative & Functional Medicine. A board-certified OB/GYN and Fellow of the American College of Obstetricians and Gynecologists, she completed her Bachelor of Science in Nutrition at Cornell University, her MD at Wayne State University School of Medicine, and her residency in Obstetrics and Gynecology at Albert Einstein College of Medicine. She is an ADAPT-trained Functional Medicine practitioner (Kresser Institute) with more than 30 years of clinical experience. View full bio →

Written by Melissa Chester, BBA. Founder and Director of Operations, InfusaLounge Integrative & Functional Medicine. A healthcare operations leader who built InfusaLounge from the ground up in 2018, with direct operational oversight of every clinical program. View full bio →

Related Articles

Low Energy and Belly Fat in Men Over 40: What to Test First

Tired, gaining belly fat, low drive — but your labs were "normal"? Here's what's actually worth testing first for men over 40, and what the numbers mean.

Read More

HBOT in Allen, TX: Inside the Two-Person OxyEdge Dual Chamber

Hyperbaric oxygen therapy (HBOT) delivers nearly 100% oxygen at higher-than-atmospheric pressure, allowing significantly more oxygen to dissolve directly into blood plasma and reach tissues with compromised circulation. At InfusaLounge in

Read More

8 Years in Allen, Texas: How InfusaLounge Became the City’s First and Longest-Running IV Therapy Clinic

When I opened InfusaLounge in April 2018, Allen had no dedicated IV therapy clinic. There were med-spas that offered an occasional drip, hospitals that ran fluids on inpatients, and primary

Read More